Filing Details

Accession Number:
0001178913-18-001110
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-04 12:28:11
Reporting Period:
2018-04-02
Accepted Time:
2018-04-04 12:28:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1606645 Foamix Pharmaceuticals Ltd. FOMX Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727794 David Domzalski C/O Foamix Pharmaceuticals Ltd.
2 Holzman Street, Weizmann Science Park
Rehovot L3 7670402
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2018-04-02 602 $5.08 139,754 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.